SULLIVAN WAY SURGERY
SULLIVAN WAY, SCHOLES, WIGAN
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 23 | 27 | 85.2% | |
| HF 4 | 2011 | 22 | 25 | 88.0% | |
| HF 4 | 2012 | 31 | 37 | 83.8% | |
| HF 4 | 2013 | 37 | 38 | 97.4% | |
| HF004 | 2014 | 31 | 32 | 96.9% | |
| HF004 | 2015 | 44 | 45 | 97.8% | |
| HF004 | 2016 | 48 | 49 | 98.0% | |
| HF004 | 2017 | 49 | 49 | 100.0% | |
| HF004 | 2018 | 50 | 51 | 98.0% | |
| HF004 | 2019 | 69 | 73 | 94.5% | |
| HF004 | 2020 | 66 | 70 | 94.3% | |
| HF006 | 2021 | 78 | 90 | 86.7% | |
| HF006 | 2022 | 79 | 79 | 100.0% | |
| HF006 | 2023 | 71 | 72 | 98.6% |
